TNSN92064A1 - Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant - Google Patents

Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant

Info

Publication number
TNSN92064A1
TNSN92064A1 TNTNSN92064A TNSN92064A TNSN92064A1 TN SN92064 A1 TNSN92064 A1 TN SN92064A1 TN TNSN92064 A TNTNSN92064 A TN TNSN92064A TN SN92064 A TNSN92064 A TN SN92064A TN SN92064 A1 TNSN92064 A1 TN SN92064A1
Authority
TN
Tunisia
Prior art keywords
same
processes
pharmaceutical compositions
compositions containing
obtaining
Prior art date
Application number
TNTNSN92064A
Other languages
English (en)
French (fr)
Inventor
Robert Bucourt
Alain Piasco
Claude Tchernatinsky
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theramex filed Critical Theramex
Publication of TNSN92064A1 publication Critical patent/TNSN92064A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TNTNSN92064A 1991-07-18 1992-07-20 Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant TNSN92064A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9109097A FR2679236B1 (fr) 1991-07-18 1991-07-18 Nouveaux sterouides substitues en position 6, leurs procedes d'obtention et des compositions pharmaceutiques en renfermant.

Publications (1)

Publication Number Publication Date
TNSN92064A1 true TNSN92064A1 (fr) 1993-06-08

Family

ID=9415270

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN92064A TNSN92064A1 (fr) 1991-07-18 1992-07-20 Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant

Country Status (14)

Country Link
EP (1) EP0595990A1 (hu)
JP (1) JPH06509108A (hu)
KR (1) KR100249554B1 (hu)
AU (2) AU2388492A (hu)
BR (1) BR9206282A (hu)
CA (1) CA2113475A1 (hu)
FI (1) FI940223A (hu)
FR (1) FR2679236B1 (hu)
HU (1) HU219456B (hu)
NO (1) NO305961B1 (hu)
OA (1) OA09929A (hu)
PL (3) PL172677B1 (hu)
TN (1) TNSN92064A1 (hu)
WO (1) WO1993002095A1 (hu)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3328729B2 (ja) 1991-06-18 2002-09-30 ラボラトアール、テラメックス、エス、ア 抗緑内障薬剤組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1515284A (en) * 1974-05-21 1978-06-21 Gastaud J Pharmaceutical compositions containing progestogens derived from the 17-alpha-hydroxy-19-nor-progesterone series
US4512986A (en) * 1983-07-26 1985-04-23 Research Triangle Institute Progrestationally active steroids
FR2552766B1 (fr) * 1983-10-04 1987-06-26 Theramex Nouveau procede de preparation de derives de la serie du 17 a-hydroxy 19-nor progesterone
FR2645864B1 (fr) * 1989-04-13 1991-07-12 Theramex Nouveaux derives alcoyles en 17/21 de la 19-nor progesterone, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant
FR2647452A1 (fr) * 1989-05-24 1990-11-30 Theramex Nouveaux 19-nor steroides 6-methyles leurs procedes d'obtention, les compositions pharmaceutiques en renfermant et leur conversion en 19-nor pregnadienes 17-substitues

Also Published As

Publication number Publication date
FR2679236B1 (fr) 1997-01-24
AU2388492A (en) 1993-02-23
HU9400134D0 (en) 1994-05-30
FI940223A0 (fi) 1994-01-17
FR2679236A1 (fr) 1993-01-22
JPH06509108A (ja) 1994-10-13
WO1993002095A1 (fr) 1993-02-04
BR9206282A (pt) 1995-10-17
AU691431B2 (en) 1998-05-14
PL172502B1 (pl) 1997-10-31
EP0595990A1 (fr) 1994-05-11
OA09929A (fr) 1994-11-15
KR100249554B1 (ko) 2000-03-15
PL172677B1 (en) 1997-11-28
AU6196696A (en) 1996-10-17
NO305961B1 (no) 1999-08-23
NO940159L (no) 1994-02-16
HUT66021A (en) 1994-08-29
CA2113475A1 (fr) 1993-02-04
FI940223A (fi) 1994-03-16
PL172522B1 (pl) 1997-10-31
NO940159D0 (no) 1994-01-17
HU219456B (hu) 2001-04-28

Similar Documents

Publication Publication Date Title
PL261349A1 (en) Method of obtaining an incorporative complex of 7-isopropoxyisoflavone with cyclodextrin
FR2377376A1 (fr) Derives d'hexahydroterphenyle et leur application en tant que cristaux liquides
NO934284L (no) Farmasoeytisk preparat inneholdende et definert lipidsystem
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
NZ292121A (en) 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-yl derivatives and pharmaceutical compositions thereof
DZ2103A1 (fr) (Méthylsulfonyl)phenyl-2-(5H)-furannones et tant qu'inhibiteurs de cox-2.
FR2422402A1 (fr) Composition a base d'ester 3-b-methoxyethylique et 5-isopropylique de 1,4-dihydro-2,6-dimethyl-4-(3'-nitrophenyl) pyridine, destinee a la therapeutique cerebrale
AU4703989A (en) Phosphinic acid substituted steroids as inhibitors of 5 alpha-reductase
DE69620291T2 (de) Nahrungszusammensetzungen in verschiedenen Formen
SE9201249L (sv) Antikonception vid primater av honkoen utan paaverkan av den menstruella cykeln
DE69231663T2 (de) Polysaccharid-protein-konjugate
FR2783713B1 (fr) Utilisation d'une gomme de silicone pour stabiliser l'acide ascorbique et nouvelles compositions contenant ces composants
NO912888D0 (no) Fremgangsmaate for fremstilling av nye peperidylethere og -thioethere.
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
ES2096727T5 (es) Productos cosmeticos y farmaceuticos que contienen extensinas.
CA2107485A1 (fr) Nouveaux derives d'ellipticine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
TNSN92064A1 (fr) Nouveaux steroides substitues en position 6 leurs procedes d'obtention et des compositions pharmaceutiques en renfermant
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
FR2446819A1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
FR2390424A1 (fr) Nouveaux derives d'amides de l'acide phenylacetique substitues, leur application en tant que medicament et leur application
FR2363324A1 (fr) Solutions aqueuses ou hydroalcooliques stables d'essences parfumees ou de medicaments solubles dans l'huile
BE830577A (fr) Derives actifs d'acide acetique, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions
BE878020A (fr) Derives n-substitues de l'acide aziridine-2-carboxylique immunostimulateurs, procedes de preparation et compositions pharmaceutiques les contenant
FR2687154B1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent.
KR970032819A (ko) 미백화장료 조성물